EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Jet‐injection assisted photodynamic therapy for superficial and nodular basal cell carcinoma: A pilot study

Leore Lavin iD, Andrés M Erlendsson iD, Saud Aleissa, Abdullah Aleisa, Christian Menzer, Stephen Dusza, Miguel Cordova, Hesham Alshaikh, Rohan Shah, Alexander Pan, Kwami Ketosugbo, Sharif Hosein und 5 weitere

Lasers in Surgery and Medicine · 2024

DOI: 10.1002/lsm.23793 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Lasers in Surgery and Medicine, 2024. Verfasst von Leore Lavin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Photochemotherapy, Skin Neoplasms, Aminolevulinic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, LEO Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Photodynamic therapy (PDT) with topical δ‐Aminolevulinic acid (ALA) has efficacy in treating basal cell carcinoma (BCC) but is limited by incomplete penetration of ALA into the deeper dermis. This prospective open‐label pilot trial investigated the safety and efficacy of photosensitizer jet injection for PDT (JI‐PDT) for BCC treatment. It was performed with 15 patients ( n = 15) with histologically confirmed, untreated, low‐risk nodular BCCs at a single institution.

Methods

For the intervention, JI‐PDT patients ( n = 11) received two sessions of jet‐injected ALA with PDT separated by four to 6 weeks. To further understand treatment technique, another group of patients ( n = 4) received jet‐injected ALA followed by tumor excision and fluorescence microscopy (JI‐E). Treatment tolerability was assessed by local skin responses (LSR) score at five distinct time intervals. Fluorescence microscopy assessed protoporphyrin IX penetration depth and biodistribution within the tumor. At the primary endpoint, tumor clearance was evaluated via visual inspection, dermoscopy and reflectance confocal microscopy. Postinjection and postillumination pain levels, and patient satisfaction, were scored on a 0−10 scale.

Results

Fifteen participants with mean age of 58.3, who were 15/15 White, non‐Hispanic enrolled. The median composite LSR score immediately after JI‐PDT was 5 (interquartile range [IQR] = 3) which decreased to 0.5 (IQR = 1) at primary endpoint ( p < 0.01). Immunofluorescence of excised BCC tumors with jet‐injected ALA showed photosensitizer penetration into papillary and reticular dermis. Of the 13 JI‐PDT tumors, 11 had tumor clearance confirmed, 1 recurred, and 1 was lost to follow‐up. 1/11 patients experienced a serious adverse event of cellulitis. 70% of patients had local scarring at 3 months. Patients reported an average pain level of 5.6 (standard deviation [SD] = 2.3) during jet injection and 3.7 (SD = 1.8) during light illumination.

Conclusions

Jet injection of ALA for PDT treatment of nodular low‐risk BCC is tolerable and feasible and may represent a novel modality to improve PDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basal Cell CarcinomaPhotochemotherapySkin NeoplasmsAminolevulinic AcidPhotosensitizing AgentsHumansPilot ProjectsFemaleMaleAgedMiddle AgedProspective StudiesInjections, JetTreatment OutcomeAged, 80 and over

Stichwörter der Autor:innen

basal cell carcinomajet‐injectornodular basal cell carcinomaphotodynamic therapy

Substanzen

Aminolevulinic AcidPhotosensitizing Agents

Autor:innen und Institutionen

  • Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Dermatology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Dermatology, King Abdulaziz University and University Hospital, Jeddah, Saudi Arabia.
  • Department of Dermatology, King Saud University, Riyadh, Saudi Arabia.
  • Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.

ORCID-Profile: Leore Lavin, Andrés M Erlendsson, Anthony Rossi

Förderung

  • NCI NIH HHS
  • NIH HHS
  • LEO Pharma
  • National Institutes of Health

Zitieren

APA

Lavin, L., Erlendsson, A. M., Aleissa, S., Aleisa, A., Menzer, C., Dusza, S., Cordova, M., Alshaikh, H., Shah, R., Pan, A., Ketosugbo, K., Hosein, S., Lee, E., Nehal, K., Togsverd-Bo, K., Haedersdal, M., & Rossi, A. (2024). Jet‐injection assisted photodynamic therapy for superficial and nodular basal cell carcinoma: A pilot study. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.23793

Vancouver

Lavin L, Erlendsson AM, Aleissa S, Aleisa A, Menzer C, Dusza S, et al. Jet‐injection assisted photodynamic therapy for superficial and nodular basal cell carcinoma: A pilot study. Lasers in Surgery and Medicine. 2024. doi:10.1002/lsm.23793

BibTeX
@article{Lavin2024,
  author = {Lavin, Leore and Erlendsson, Andrés M and Aleissa, Saud and Aleisa, Abdullah and Menzer, Christian and Dusza, Stephen and Cordova, Miguel and Alshaikh, Hesham and Shah, Rohan and Pan, Alexander and Ketosugbo, Kwami and Hosein, Sharif and Lee, Erica and Nehal, Kishwer and Togsverd-Bo, Katrine and Haedersdal, Merete and Rossi, Anthony},
  title = {Jet‐injection assisted photodynamic therapy for superficial and nodular basal cell carcinoma: A pilot study},
  journal = {Lasers in Surgery and Medicine},
  year = {2024},
  doi = {10.1002/lsm.23793}
}
Kostenlos starten →